Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum
27. Juni 2023 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., June 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Synlogic Announces Participation in Upcoming Investor and Industry Conferences
24. Januar 2023 06:57 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced it will participate in the...